Guardant Health (GH) Equity Average (2018 - 2026)

Guardant Health (GH) has 9 years of Equity Average data on file, last reported at -$140.2 million in Q1 2026.

• Quarterly Equity Average rose 28.19% year-over-year to -$140.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$140.2 million (up 28.19% YoY) and the FY2025 annual result came in at -$119.5 million, down 1355.21% from the prior year.
• Equity Average rose to -$140.2 million in Q1 2026 per GH's latest filing, from -$226.9 million in the prior quarter.
• The five-year high for Equity Average was $589.0 million in Q1 2022, with the low at -$330.0 million in Q3 2025.
• Average Equity Average over 5 years is $47.2 million, with a median of $33.3 million recorded in 2024.
• Year-over-year, Equity Average surged 1352.23% in 2024 and plunged 969.45% in 2025.
• Guardant Health's Equity Average stood at $113.5 million in 2022, then jumped by 70.53% to $193.5 million in 2023, then slumped by 151.62% to -$99.9 million in 2024, then plunged by 127.18% to -$226.9 million in 2025, then jumped by 38.21% to -$140.2 million in 2026.
• Business Quant data shows GH's Equity Average at -$140.2 million in Q1 2026, -$226.9 million in Q4 2025, and -$330.0 million in Q3 2025.